Articles from Ionetix Corporation

Ionetix Corporation ("Ionetix" or the "Company"), a manufacturer of proprietary superconducting cyclotrons and producer of medical isotopes for diagnostic imaging and targeted alpha therapy, today announced the appointment of Paul Surdez as Head of Investor Relations. Mr. Surdez brings more than 25 years of investor relations and corporate communications leadership, including senior investor relations roles at S&P 500 healthcare companies. The appointment follows Ionetix’s April 2026 reverse merger with JDEV Acquisition Corp. and related $30 million-plus private placement.